• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Causality assessment: Which is best-expert opinion or RUCAM?

作者信息

Lewis James H

机构信息

Division of Gastroenterology and Hepatology Georgetown University Hospital Washington DC.

出版信息

Clin Liver Dis (Hoboken). 2014 Jul 25;4(1):4-8. doi: 10.1002/cld.365. eCollection 2014 Jul.

DOI:10.1002/cld.365
PMID:30992910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448723/
Abstract
摘要

相似文献

1
Causality assessment: Which is best-expert opinion or RUCAM?因果关系评估：专家意见和RUCAM哪个更好？
Clin Liver Dis (Hoboken). 2014 Jul 25;4(1):4-8. doi: 10.1002/cld.365. eCollection 2014 Jul.
2
Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.一种旨在支持药物性肝损伤常规药物警戒病例报告初始因果关系评估的新型算法方法的初步结果：PV-RUCAM
Drug Saf. 2017 Aug;40(8):715-727. doi: 10.1007/s40264-017-0541-2.
3
Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?药物性肝损伤：为何在其问世 25 年后 Roussel Uclaf 因果关系评估方法（RUCAM）仍在使用？
Drug Saf. 2018 Aug;41(8):735-743. doi: 10.1007/s40264-018-0654-2.
4
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases.亚洲草药性肝损伤及RUCAM在11160例已发表病例因果关系评估中的当前作用
J Clin Transl Hepatol. 2020 Jun 28;8(2):200-214. doi: 10.14218/JCTH.2020.00009. Epub 2020 Apr 24.
5
Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.使用罗塞尔·优克福因果关系评估方法（RUCAM）分析一项临床试验项目中的肝脏检查结果：直接凝血酶抑制剂希美加群的评估
Int J Clin Pharmacol Ther. 2008 Jul;46(7):327-39. doi: 10.5414/cpp46327.
6
An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.一种用于在电子病历数据中检测药物性肝损伤的自动化因果关系评估算法。
Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):601-8. doi: 10.1002/pds.3531. Epub 2013 Oct 21.
7
Causality assessment for suspected DILI during clinical phases of drug development.药物研发临床阶段疑似药物性肝损伤的因果关系评估。
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4.
8
Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.单核细胞来源的肝细胞样细胞用于评估药物所致肝损伤的体质性因果关系。
Gut. 2016 Sep;65(9):1555-63. doi: 10.1136/gutjnl-2015-309528. Epub 2015 Jun 4.
9
Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).采用多学科方法和鲁塞尔乌克劳夫因果关系评估方法（RUCAM）评估草药性肝损伤的因果关系。
Clin Toxicol (Phila). 2011 Jan;49(1):34-9. doi: 10.3109/15563650.2010.537662. Epub 2010 Nov 29.
10
Suspected Liver Injury and the Dilemma of Causality.疑似肝损伤与因果关系的困境
Dig Dis Sci. 2017 Apr;62(4):1095-1098. doi: 10.1007/s10620-016-4442-5. Epub 2017 Feb 16.

引用本文的文献

1
Model of baseline clinicopathological features predicts non-resolution of drug-induced liver injury at 6 months.基线临床病理特征模型可预测药物性肝损伤6个月时未缓解的情况。
Hepatol Int. 2025 Jun;19(3):633-646. doi: 10.1007/s12072-025-10814-6. Epub 2025 Apr 3.
2
Methods for causality assessment of idiosyncratic drug-induced liver injury.特异质性药物性肝损伤的因果关系评估方法。
Liver Int. 2025 Mar;45(3):e16083. doi: 10.1111/liv.16083. Epub 2024 Aug 21.
3
Probable Enoxaparin-Induced Liver Injury in a Young Patient: A Case Report of a Diagnostic Challenge.一名年轻患者可能由依诺肝素引起的肝损伤：诊断挑战的病例报告
Cureus. 2023 Mar 29;15(3):e36869. doi: 10.7759/cureus.36869. eCollection 2023 Mar.
4
Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract.偏头痛草药治疗中的肝胆事件——以Petadolex（一种蜂斗菜提取物）为例
J Clin Med. 2019 May 10;8(5):652. doi: 10.3390/jcm8050652.
5
The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity.草药和膳食补充剂相关性肝毒性数据库的建立。
Int J Mol Sci. 2018 Sep 28;19(10):2955. doi: 10.3390/ijms19102955.
6
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.利福平治疗胆汁淤积性瘙痒症时肝毒性风险低：一种跨疾病队列研究。
Aliment Pharmacol Ther. 2018 Apr;47(8):1213-1219. doi: 10.1111/apt.14579. Epub 2018 Feb 22.
7
Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers.与非饮酒者相比，特发性药物性肝损伤患者大量饮酒与更差的结局无关。
Clin Gastroenterol Hepatol. 2018 May;16(5):722-729.e2. doi: 10.1016/j.cgh.2017.12.036. Epub 2018 Jan 3.
8
Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.药物亲脂性及代谢程度与药物性肝损伤的关联
Int J Mol Sci. 2017 Jun 22;18(7):1335. doi: 10.3390/ijms18071335.
9
Drug-induced liver injury: Do we know everything?药物性肝损伤：我们了解一切了吗？
World J Hepatol. 2017 Apr 8;9(10):491-502. doi: 10.4254/wjh.v9.i10.491.
10
Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.药物性肝损伤：2015年文献综述要点
Drug Saf. 2016 Sep;39(9):801-21. doi: 10.1007/s40264-016-0427-8.

本文引用的文献

1
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.应用 Hy's 法则和一种新的复合算法预测药物性肝损伤患者的急性肝衰竭。
Gastroenterology. 2014 Jul;147(1):109-118.e5. doi: 10.1053/j.gastro.2014.03.050. Epub 2014 Apr 1.
2
Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.急性药物性肝损伤患者血清细胞因子谱及其预后意义
PLoS One. 2013 Dec 27;8(12):e81974. doi: 10.1371/journal.pone.0081974. eCollection 2013.
3
Managing the risk of drug-induced liver injury.药物性肝损伤的风险管理。
Clin Pharmacol Ther. 2013 Dec;94(6):629-31. doi: 10.1038/clpt.2013.182.
4
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.疑似药物性肝损伤的肝组织学发现：系统评价和临床关联。
Hepatology. 2014 Feb;59(2):661-70. doi: 10.1002/hep.26709. Epub 2013 Dec 18.
5
Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.草药性肝毒性：因果关系评估方法的挑战和误区。
World J Gastroenterol. 2013 May 21;19(19):2864-82. doi: 10.3748/wjg.v19.i19.2864.
6
Review article: prescribing medications in patients with cirrhosis - a practical guide.综述文章：肝硬化患者的药物处方 - 实用指南。
Aliment Pharmacol Ther. 2013 Jun;37(12):1132-56. doi: 10.1111/apt.12324. Epub 2013 May 3.
7
LiverTox: a website on drug-induced liver injury.LiverTox：一个关于药物性肝损伤的网站。
Hepatology. 2013 Mar;57(3):873-4. doi: 10.1002/hep.26175.
8
Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.机制生物标志物可在首次就诊时提供对乙酰氨基酚引起的急性肝损伤的早期和敏感检测。
Hepatology. 2013 Aug;58(2):777-87. doi: 10.1002/hep.26294. Epub 2013 Jul 2.
9
Pharmacogenomics of adverse drug reactions.药物不良反应的药物基因组学
Genome Med. 2013 Jan 29;5(1):5. doi: 10.1186/gm409. eCollection 2013.
10
Assessment of emerging biomarkers of liver injury in human subjects.评估人类受试者肝损伤的新兴生物标志物。
Toxicol Sci. 2013 Apr;132(2):276-83. doi: 10.1093/toxsci/kft009. Epub 2013 Jan 20.